Trademark: 98004249
Word
SCAD
Status
Pending
Status Code
645
Status Date
Tuesday, April 2, 2024
Serial Number
98004249
Mark Type
4000
Filing Date
Friday, May 19, 2023

Trademark Owner History

Classifications
42 Research and development in the field of oligonucleotide drug delivery platforms for use in the treatment of genetic diseases and disorders; research and development in the field of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; and research and development in the field of oligonucleotide compounds for targeted gene silencing.

Trademark Events
Apr 2, 2024
Notification Of Final Refusal Emailed
Apr 2, 2024
Final Refusal E-Mailed
Apr 2, 2024
Final Refusal Written
Feb 28, 2024
Teas/Email Correspondence Entered
Feb 28, 2024
Correspondence Received In Law Office
Feb 28, 2024
Teas Response To Office Action Received
Feb 22, 2024
Notification Of Non-Final Action E-Mailed
Feb 22, 2024
Non-Final Action E-Mailed
Feb 22, 2024
Non-Final Action Written
Feb 13, 2024
Assigned To Examiner
Jun 21, 2023
New Application Office Supplied Data Entered
May 23, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24